证券记录 · 已归档季度
GKOS
Glaukos Corporation · Healthcare · Medical - Devices
22被追踪持有人
+5Δ持有人
29.69M持有股份
$2.42B报告持仓市值
+5新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +29.4% ·
股份流向 -13.0% ·
净新建仓位 +18.2%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 123 | +9 | 42.81M | $5.94B | +15 | −7 |
| Q1 2026 | 118 | -1 | 46.55M | $5.02B | +6 | −8 |
| Q4 2025 | 118 | 0 | 48.22M | $5.44B | +2 | −1 |
| Q3 2025 | 22 | +5 | 29.69M | $2.42B | +5 | −1 |
| Q2 2025 | 15 | -2 | 32.65M | $3.37B | +1 | −3 |
| Q1 2025 | 14 | -2 | 8.81M | $867.57M | +1 | −3 |
| Q4 2024 | 16 | -1 | 9.74M | $1.46B | — | −1 |
| Q3 2024 | 16 | 0 | 7.06M | $919.99M | +1 | −1 |
| Q2 2024 | 16 | — | 6.75M | $798.69M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 8.66M | -0.8% | $705.88M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (被动) | 6.05M | -1.1% | $493.09M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Wellington Management ✦ | 3.58M | +10.4% | $292.00M | 0.1% | ▲ Add | 6 | SEC ↗ ×5 |
| 4 | PRIMECAP Management ✦ | 2.25M | +23.3% | $183.80M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (被动) | 2.10M | +0.7% | $171.61M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | JPMorgan Chase ✦ | 1.34M | — | $109.29M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 7 | Geode Capital Management ✦ (被动) | 1.32M | -1.1% | $107.34M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 913.41K | 新增 | $74.49M | 0.1% | New | 1 | SEC ↗ |
| 9 | Capital World Investors ✦ | 850.89K | 0.0% | $69.39M | 0.0% | Held | 6 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 690.72K | -4.0% | $56.33M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 436.97K | — | $35.63M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 12 | Morgan Stanley ✦ | 429.58K | — | $35.03M | 0.0% | n/c | 1 | SEC ↗ ×11 |
| 13 | Marshall Wace ✦ | 324.53K | +40.7% | $26.47M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 14 | D. E. Shaw & Co. ✦ | 278.44K | 新增 | $22.71M | 0.0% | New | 1 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 121.41K | -98.1% | $9.90M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 16 | T. Rowe Price ✦ | 116.91K | +8.7% | $9.53M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | Two Sigma Investments ✦ | 66.94K | 新增 | $5.46M | 0.0% | New | 1 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 57.89K | 新增 | $4.72M | 0.0% | New | 1 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 55.94K | -82.5% | $4.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 28.58K | 新增 | $2.33M | 0.0% | New | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 10.32K | +62.7% | $841,343 | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 22 | GAMCO Investors ✦ | 8.10K | +1.2% | $660,555 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Millennium Management | $74.49M | 0.1% |
| D. E. Shaw & Co. | $22.71M | 0.0% |
| Two Sigma Investments | $5.46M | 0.0% |
| Renaissance Technologies | $4.72M | 0.0% |
| Adage Capital Partners | $2.33M | 0.0% |
已清仓
| Norges Bank | $76.31M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 333 持有人, 57.55M 股份, $6.09B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 05
Navratil Tomas
Officer · 888 股 · $145,570
Oct 05
Navratil Tomas
Officer · 312 股 · $51,667
Oct 05
Navratil Tomas
Officer · 327 股 · $53,883
Sep 25
Navratil Tomas
Officer · 167 股 · $25,334
Sep 25
Navratil Tomas
Officer · 1.08K 股 · $167,735
Sep 25
Navratil Tomas
Officer · 229 股 · $35,321
Sep 25
Navratil Tomas
Officer · 136 股 · $20,769
Sep 16
Navratil Tomas
Officer · 103 股 · $16,810
Sep 16
Navratil Tomas
Officer · 345 股 · $56,787
Sep 16
Navratil Tomas
Officer · 191 股 · $31,744
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据